Trial Profile
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy. (YELLOW Trial)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin; Simvastatin
- Indications Angina pectoris; Coronary arteriosclerosis; Coronary artery disease
- Focus Therapeutic Use
- Acronyms YELLOW
- 10 Apr 2012 New trial record